Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 2Asthma 2Smoking 1Pulmonary Disease, Chronic Obstructive 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Multiple Myeloma 1Lymphoma, Follicular 1Leukemia, Plasma Cell 1Leukemia 1Hematologic Neoplasms 1Graft vs Host Disease 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1

Interventions

Standard of Care 3Educational Status 2vilanterol 1tocilizumab 1perflutren 1X-Rays 1Tiotropium Bromide 1Therapeutics 1Telemedicine 1Tablets 1Surgical Procedures, Operative 1Sulfur Hexafluoride 1Specimen Handling 1Singing 1Salmeterol Xinafoate 1Rehabilitation 1Pulmonary Surgical Procedures 1Prednisolone 1Practice Guidelines as Topic 1Pharmacists 1Methods 1Massage 1Magnesium Sulfate 1Lysine Acetyltransferase 5 1Immunoglobulin G 1Iloprost 1Hypnosis 1Hematologic Tests 1Geritol 1General Practitioners 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pulmonary Disease, Chronic Obstructive × Budesonide × Clear all
NCT02504801 2015-07-22

Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD

Xuanwu Hospital, Beijing

Phase 4 Unknown
73 enrolled
Thoracic

Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡